2006
DOI: 10.1016/j.bbrc.2006.05.201
|View full text |Cite
|
Sign up to set email alerts
|

Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
51
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
1
1

Relationship

4
4

Authors

Journals

citations
Cited by 31 publications
(53 citation statements)
references
References 36 publications
2
51
0
Order By: Relevance
“…The peptides were synthesized on solid phase and purified to homogeneity by RPLC, 20,35 with purity confirmed by CZE. 21 The peptides were first screened one at a time with the peptide Syntide 2 (St) of similar (but not overlapping) m = 1508 Da as the internal calibrant.…”
Section: Experimental Methodsmentioning
confidence: 99%
“…The peptides were synthesized on solid phase and purified to homogeneity by RPLC, 20,35 with purity confirmed by CZE. 21 The peptides were first screened one at a time with the peptide Syntide 2 (St) of similar (but not overlapping) m = 1508 Da as the internal calibrant.…”
Section: Experimental Methodsmentioning
confidence: 99%
“…The concentrations of the purified peptides as well as the synthetic ones were determined using tyrosine absorption (e 280 = 1290 M -1 cm (Fields and Noble 1990) using a Syro2000 multiple peptide synthesizer (MultiSynTech GmbH, Witten, Germany) (Singer et al 2006). After completion of the peptide synthesis, the peptides were cleaved with 5% water, 4% m-cresol, 5% thioanisole and 2% ethanedithiol in trifluoroacetic acid (TFA) at room temperature for 4 h and precipitated with cold diethyl ether.…”
Section: Sequence Analysismentioning
confidence: 99%
“…They were synthesized as C-terminal amides on a Syro 2000 multiple peptide synthesizer (MultiSynTech GmbH, Witten, Germany) equipped with a 48-vessel reaction block using standard 9-fluorenylmethoxycarbonyl(Fmoc)/tert.-butyl chemistry [21]. Sites to be phosphorylated were incorporated without side-chain protection as Fmoc-Ser-OH or Fmoc-Thr-OH and globally phosphorylated by the phosphoamidite approach [20,22]. After cleavage with TFA the crude peptides were purified on a Jupiter C 18 -column (Phenomenex, Torrance, USA) with a linear aqueous acetonitrile gradient in the presence of 0.1% v/v TFA.…”
mentioning
confidence: 99%